British trio four shots off lead at US Women's Open
US Open first round leaderboard-4 Yin (US), Lopez (Spa), Takeda (Jpn) Noh (US), Im (Kor), Kim (Kor); -3 Iwai (Jpn), Hatoaka (Jpn), Tamburlini (Swi), Hwang (Kor), Kawamoto (Kor)Selected others: E Dryburgh (Sco), Hull (Eng), Woad (Eng), Korda (US); +1 Lee (Aus); +2 Saso (Jpn)Full leaderboard
British trio Charley Hull, Gemma Dryburgh and Lottie Woad sit four shots off the lead, alongside world number one Nelly Korda, after the first round of the US Women's Open. They are all at level par on a congested leaderboard at Erin Hills in Wisconsin.American world number 11 Angel Yin and 2020 champion A Lim Kim are among six players in the joint lead on four under after a day when 58 players shot level par or better. England's Hull, who was two over after 11 holes, hit birdies on the 12th and 16th holes to post a 72 and match the efforts of Scotland's Dryburgh who birdied the 13th and 14th holes to wipe out early bogeys.Amateur Lottie Woad, who won the prestigious Augusta National Women's Amateur in 2024, was three under after 10 holes but a double-bogey six on the par-four 17th saw her drop back.Two-time major winner Korda had one bogey and one birdie in her 72."Overall, I can't complain," said the American. "First day, it's all about patience. I'm striking it pretty well, so hopefully I can carry that into the next couple days."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
28 minutes ago
- Reuters
Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression
May 31 (Reuters) - An experimental treatment by Pfizer (PFE.N), opens new tab and Arvinas (ARVN.O), opens new tab delayed progression of breast cancer by more than three months compared to AstraZeneca's (AZN.L), opens new tab Faslodex in patients with a specific gene mutation, according to trial results announced on Saturday. The findings were presented in Chicago at the annual meeting of the American Society of Clinical Oncology and published in The New England Journal of Medicine. The trial found the experimental drug vepdegestrant increased survival without progression of the disease in patients with ESR1 mutations by five months, compared to about two months for Faslodex. The findings followed initial results of the study in March. Those showed the benefit of vepdegestrant in patients with the mutations but failed to show benefit in a larger set of patients, sending Arvinas' shares to a record low. Saturday's more detailed data showed vepdegestrant increased survival in the larger group of patients by 3.8 months, versus 3.6 months for Faslodex. The late-stage study enrolled 624 previously treated patients with a type of breast cancer that accounts for nearly 70% of all such cancers. Erica Hamilton, one of the authors of the study, said that Faslodex "clearly has some challenges now," adding that it is injected into a muscle, versus vepdegestrant's more convenient oral dosing. Vepdegestrant belongs to a novel class of drugs called PROTAC ER degraders, which are designed to harness the body's natural protein disposal system to specifically target and degrade proteins that spur tumor growth. Breast cancer accounts for about one-third of all new female cancers each year in the U.S., according to the American Cancer Society. Approved treatments for this type of advanced breast cancer include Eli Lilly's (LLY.N), opens new tab Verzenio, Pfizer's Ibrance and Novartis' (NOVN.S), opens new tab Kisqali. Leerink Partners analyst Andrew Berens expects vepdegestrant to earn $576 million in peak sales in 2032. Earlier this month, Arvinas said that it will not move forward with two other planned late-stage studies of the drug.
The Independent
35 minutes ago
- The Independent
Trump fast-tracks Utah uranium mine, but industry revival may wait for higher prices
In the southeastern Utah desert famous for red rock arches and canyon labyrinths, the long-dormant uranium mining industry is looking to revive under President Donald Trump. Hundreds of abandoned uranium mines dot the West's arid landscapes, hazardous reminders of the promise and peril of nuclear power during the Cold War. Now, one mine that the Trump administration fast-tracked for regulatory approval could reopen for the first time since the 1980s. Normally it would have taken months, if not years, for the U.S. Bureau of Land Management to review plans to reopen a project like Anfield Energy's Velvet-Wood mine 35 miles (56 kilometers) south of Moab. But the bureau's regulators green-lit the project in just 11 days under a 'national energy emergency' Trump has declared that allows expedited environmental reviews for energy projects. More permits and approvals will be needed, plus site work to get the mine operating again. And the price of uranium would have to rise enough to make domestic production financially sustainable. If that happens, it would mean revival — and jobs — to an industry that locally has been moribund since the Ronald Reagan era. 'President Trump has made it clear that our energy security is national security," Interior Secretary Doug Burgum said in announcing the fast-tracking policy in April. 'These emergency procedures reflect our unwavering commitment to protecting both.' More fast approvals appear likely. Trump's order also applies to oil, gas, coal, biofuel and hydropower projects — but not renewable energy — on federal lands. Conditions are ripe for more U.S. uranium mining Global uranium prices are double what they were at a low point seven years ago and, for the past year, the U.S. has banned uranium imports from Russia due to that country's 2022 invasion of Ukraine. More domestic mining would address a major imbalance. The U.S. imports about 98% of the uranium it uses to generate 30% of the world's nuclear energy. More than two-thirds of U.S. imports come from the world's top three uranium-mining countries: Canada, Australia and Kazakhstan. Less government regulation won't spur more U.S. uranium mining by itself. The market matters. And while spot-market prices are up from several years ago, they're down about a third from their recent high in early 2024. While some new uranium mining and processing projects have been announced, their number falls far short of a surge. That suggests prices need to rise — and stay there — for a true industry revival, said John Uhrie, a former uranium executive who now works in the cement industry. 'Until the price goes up dramatically, you're not going to be able to actually put these places into operation,' Uhrie said. 'You need significant capital on the ground.' Still, the industry is showing new life in the Southwest. Anfield Energy, a Canadian company, also looks to reopen the Shootaring Canyon uranium mill in southern Utah near Glen Canyon National Recreation Area. It closed in the early 1980s. A uranium mill turns raw ore into yellowcake, a powdery substance later processed elsewhere into nuclear fuel. Anfield officials did not return messages seeking comment on plans to reopen the mill and the Velvet-Wood mine. Energy Fuels, another Canadian company which ranks as the top U.S. uranium miner, opened the Pinyon Plain mine about 10 miles (16 kilometers) from the Grand Canyon in late 2023. And just off U.S. 191 in southeastern Utah is a hub of the industry, Uranium Fuels' White Mesa mill, the country's only uranium mill still in operation. In Moab, uranium has a long — and mixed — legacy These days, Moab is a desert tourism hot spot bustling with outdoor enthusiasts. But the town of 5,200 has a deeper history with uranium. Nods to Moab's post-World War II mining heyday can been spotted around town — the Atomic Hair Salon isn't just named for its blowout hairstyles. The biggest reminder is the Moab Uranium Mill Tailings Remedial Action project, a 480-acre (194-hectare) site just outside town. The decades-long, $1 billion U.S. Department of Energy effort to haul off toxic tailings that were leaching into the Colorado River upstream from the Grand Canyon and Lake Mead should wrap up within five more years. That mill's polluting legacy makes some Moab residents wary of restarting uranium mining and processing, especially after the Trump administration cut short their ability to weigh in on the Velvet-Wood mine plans. 'This was a process I would have been involved in,' said Sarah Fields, director of the local group Uranium Watch. 'They provided no opportunity for the public to say, 'You need to look at this, you need to look at that.'" Grand Canyon Trust, a group critical of the Pinyon Plain mine as a danger to groundwater, points out that the U.S. nuclear industry isn't at risk of losing access to uranium. 'This is all being done under the assumption there is some energy emergency and that is just not true,' said Amber Reimondo, the group's energy director. Supply and demand will decide uranium mining's future Hundreds of miles to the north, other nuclear energy projects point to the U.S. industry's future. With Bill Gates' support, TerraPower is building a 345-megawatt sodium-cooled fast reactor outside Kemmerer in western Wyoming that could, in theory, meet demand for carbon-free power at lower costs and with less construction time than conventional reactor units. Meanwhile, about 40% of uranium mined in the U.S. in 2024 came from four Wyoming 'in-situ' mines that use wells to dissolve uranium in underground deposits and pump it to the surface without having to dig big holes or send miners underground. Similar mines in Texas and Nebraska and stockpiled ore processed at White Mesa accounted for the rest. None — as yet — came from mines in Utah. Powering electric cars and computing technology will require more electricity in the years ahead. Nuclear power offers a zero-carbon, round-the-clock option. Meeting the demand for nuclear fuel domestically is another matter. With prices higher, almost 700,000 pounds of yellowcake was produced in the U.S. in 2024 — up more than a dozen-fold from the year before but still far short of the 32 million pounds imported into the U.S. Even if mining increases, it's not clear that U.S. capacity to turn the ore into fuel would keep pace, said Uhrie, the former uranium mining executive. "Re-establishing a viable uranium industry from soup to nuts — meaning from mining through processing to yellow cake production, to conversion, to enrichment to produce nuclear fuel — remains a huge lift," Uhrie said. ___
BreakingNews.ie
43 minutes ago
- BreakingNews.ie
X marks the spot: Bruised Musk says his young son punched him
A bruised Elon Musk explained away a black eye during a White House appearance on Friday by saying that his five-year-old son had punched him in the face while the two were playing around. Mr Musk made the comments during an Oval Office event with Donald Trump marking the end of the billionaire's formal cost-cutting role in the president's administration. Advertisement Mr Musk's visibly bruised right eye caught reporters' attention. Asked about the injury, Mr Musk said he was "horsing around" with his son, who is named X. "And I said, 'Go ahead, punch me in the face.' And he did," Mr Musk said. Mr Trump then interjected. "That was X that did that? ...X could do it. If you knew X." When he was initially asked about the bruise, Mr Musk brushed it off with his usual cryptic humour. "I wasn't anywhere near France," he quipped, referencing a recent incident where president Emmanuel Macron's wife shoved him in the face. Mr Musk said he didn't feel much at the time but it bruised later. The Tesla CEO is leaving the Trump administration after leading a tumultuous cost-cutting drive, during which he upended several federal agencies but ultimately failed to deliver the generational savings he had sought.
